Clinical evaluation of the Hydra self-expanding THV: 30-day results from the GENESIS-II study
The Hydra THV is the first device with an active release mechanism for deploying the supra-annular valve. The observed high rates of device success and procedural safety in the GENESIS-II study may support the continued safety and performance of the device.
Authors
- Anmol Sonawane
- Nagendra Boopathy Senguttuvan (ORCID: https://orcid.org/0000-0003-4979-596X)
- John Jose
- Sandeep Bansal (ORCID: https://orcid.org/0000-0002-1607-4077)
- Rahul Gupta (ORCID: https://orcid.org/0000-0002-2511-2119)
- Praveen Chandra
Institutions
- Medanta The Medicity (IN)
- Safdarjang Hospital (IN)
- Christian Medical College, Vellore (IN)
- Sri Ramachandra Institute of Higher Education and Research (IN)
- Breach Candy Hospital (IN)
- Medanta The Medicity (IN)
- Apollo Hospitals (IN)
- Apollo Hospitals (IN)
Publication Details
- Journal
- AsiaIntervention
- Published
- 2025-10-01
- DOI
- https://doi.org/10.4244/aij-d-24-00075
- Citations
- 2
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 2.78